BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21495163)

  • 1. Pentostatin for treatment of refractory autoimmune lymphoproliferative syndrome.
    Bajwa R; Savelli S; Gross T
    Pediatr Blood Cancer; 2011 Aug; 57(2):336-7. PubMed ID: 21495163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory drugs in autoimmune lymphoproliferative syndrome (ALPS).
    Tommasini A; Valencic E; Piscianz E; Rabusin M
    Pediatr Blood Cancer; 2012 Feb; 58(2):310; author reply 311. PubMed ID: 21674759
    [No Abstract]   [Full Text] [Related]  

  • 3. Childhood polyarteritis nodosa in autoimmune lymphoproliferative syndrome.
    Naumann-Bartsch N; Stachel D; Morhart P; Staatz G; Jüngert J; Schwarz K; Holter W
    Pediatrics; 2010 Jan; 125(1):e169-73. PubMed ID: 20026502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.
    Hensel M; Ho AD
    Am J Hematol; 2003 May; 73(1):37-40. PubMed ID: 12701118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
    Li P; Huang P; Yang Y; Hao M; Peng H; Li F
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history.
    Ries F; Ferster A; Rieux-Laucat F; Biwer A; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):271-8. PubMed ID: 20882745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune lymphoproliferative syndrome (ALPS): a case with congenital onset.
    Kahwash SB; Fung B; Savelli S; Bleesing JJ; Qualman SJ
    Pediatr Dev Pathol; 2007; 10(4):315-9. PubMed ID: 17638424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.
    Cayrol J; Garrido Colino C
    J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underexpression and overexpression of Fas and Fas ligand: a double-edged sword.
    Randhawa SR; Chahine BG; Lowery-Nordberg M; Cotelingam JD; Casillas AM
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):286-92. PubMed ID: 20408337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
    Cesaro S; Locatelli F; Lanino E; Porta F; Di Maio L; Messina C; Prete A; Ripaldi M; Maximova N; Giorgiani G; Rondelli R; Aricò M; Fagioli F
    Haematologica; 2008 Nov; 93(11):1694-701. PubMed ID: 18768529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentostatin for the treatment of indolent lymphoproliferative disorders.
    Ho AD; Hensel M
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S2-10. PubMed ID: 16549110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentostatin (Nipent) and high-dose cyclophosphamide for the treatment of refractory autoimmune disorders.
    Goodman M
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):67-71. PubMed ID: 10877056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation.
    Barzaghi F; Minniti F; Mauro M; Bortoli M; Balter R; Bonetti E; Zaccaron A; Vitale V; Omrani M; Zoccolillo M; Brigida I; Cicalese MP; Degano M; Hershfield MS; Aiuti A; Bondarenko AV; Chinello M; Cesaro S
    Front Immunol; 2018; 9():2767. PubMed ID: 30692987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune lymphoproliferative syndrome].
    Rodrigues V; Conde M; Figueiredo A; Vasconcelos J; Dias A
    Acta Med Port; 2011; 24(5):833-6. PubMed ID: 22525637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune lymphoproliferative syndrome in pregnancy: a case of favorable mother-fetal outcome in a well-controlled disease.
    Patti S; Perrone G; De Pratti V; Quinti I; Milito C; Brunelli R
    J Obstet Gynaecol Res; 2015 Mar; 41(3):460-3. PubMed ID: 25302402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune lymphoproliferative syndrome. Update and review].
    Suárez-Gutiérrez M; Yamazaki-Nakashimada MA; Espinosa S; Blancas-Galicia L; Lugo-Reyes SO; Álvarez-Cardona A
    Rev Alerg Mex; 2019; 66(4):456-473. PubMed ID: 32105427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy cell leukemia: an elusive but treatable disease.
    Wanko SO; de Castro C
    Oncologist; 2006; 11(7):780-9. PubMed ID: 16880237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.